Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS

De Ferrari, GM; Stevens, SR; Ambrosio, G; Leonardi, S; Armstrong, PW; Green, JB; Wamil, M; Holman, RR; Peterson, ED

De Ferrari, GM (corresponding author), Univ Torino, Div Cardiol, Citta Salute & Sci Torino, I-10126 Turin, Italy.

AMERICAN HEART JOURNAL, 2020; 220 (): 82

Abstract

Background Type 2 diabetes (T2D) patients are at increased risk for cardiovascular (CV) events. Most guidelines recommend treating low-density lipopro......

Full Text Link